Aβ conformer selective anti-Aβ globulomer monoclonal antibodies

The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized)...

Full description

Saved in:
Bibliographic Details
Main Authors Striebinger, Andreas R, Barghorn, Stefan, Keller, Patrick, Labkovsky, Boris, Ebert, Ulrich, Hillen, Heinz
Format Patent
LanguageEnglish
Published 24.04.2018
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Bibliography:Application Number: US201615155739